These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 35273921)

  • 21. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets.
    Tie Y; Huang Y; Chen R; Li L; Chen M; Zhang S
    Gut Microbes; 2023 Dec; 15(2):2265028. PubMed ID: 37822139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease.
    Thomas JP; Modos D; Rushbrook SM; Powell N; Korcsmaros T
    Front Immunol; 2022; 13():829525. PubMed ID: 35185922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential of EGCG in modulating the oral-gut axis microbiota for treating inflammatory bowel disease.
    Ge J; Li M; Yao J; Guo J; Li X; Li G; Han X; Li Z; Liu M; Zhao J
    Phytomedicine; 2024 Jul; 130():155643. PubMed ID: 38820660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial peptides and the gut microbiome in inflammatory bowel disease.
    Gubatan J; Holman DR; Puntasecca CJ; Polevoi D; Rubin SJ; Rogalla S
    World J Gastroenterol; 2021 Nov; 27(43):7402-7422. PubMed ID: 34887639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal Maternal Stress Exacerbates Experimental Colitis of Offspring in Adulthood.
    Sun Y; Xie R; Li L; Jin G; Zhou B; Huang H; Li M; Yang Y; Liu X; Cao X; Wang B; Liu W; Jiang K; Cao H
    Front Immunol; 2021; 12():700995. PubMed ID: 34804005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.
    Kudelka MR; Stowell SR; Cummings RD; Neish AS
    Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):597-617. PubMed ID: 32710014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease.
    Yue B; Yu ZL; Lv C; Geng XL; Wang ZT; Dou W
    World J Gastroenterol; 2020 Aug; 26(30):4378-4393. PubMed ID: 32874052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.
    Cohen LJ; Cho JH; Gevers D; Chu H
    Gastroenterology; 2019 Jun; 156(8):2174-2189. PubMed ID: 30880022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.
    Pickard JM; Zeng MY; Caruso R; Núñez G
    Immunol Rev; 2017 Sep; 279(1):70-89. PubMed ID: 28856738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease.
    He P; Yu L; Tian F; Zhang H; Chen W; Zhai Q
    Adv Nutr; 2022 Oct; 13(5):1628-1651. PubMed ID: 35348593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between intestinal microbiota and inflammatory bowel disease.
    Zhang Y; Si X; Yang L; Wang H; Sun Y; Liu N
    Animal Model Exp Med; 2022 Dec; 5(4):311-322. PubMed ID: 35808814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Gut Microbiome and Inflammatory Bowel Diseases.
    Shan Y; Lee M; Chang EB
    Annu Rev Med; 2022 Jan; 73():455-468. PubMed ID: 34555295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis.
    Zheng J; Sun Q; Zhang J; Ng SC
    United European Gastroenterol J; 2022 Dec; 10(10):1091-1102. PubMed ID: 36461896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired Autophagy in Intestinal Epithelial Cells Alters Gut Microbiota and Host Immune Responses.
    Yang L; Liu C; Zhao W; He C; Ding J; Dai R; Xu K; Xiao L; Luo L; Liu S; Li W; Meng H
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
    Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
    World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.